Skip to main content
Top
Published in: Archives of Virology 7/2014

01-07-2014 | Brief Report

Mutations in the FPIV motif of Newcastle disease virus matrix protein attenuate virus replication and reduce virus budding

Authors: Zhiqiang Duan, Zenglei Hu, Jie Zhu, Haixu Xu, Jian Chen, Huimou Liu, Shunlin Hu, Xiufan Liu

Published in: Archives of Virology | Issue 7/2014

Login to get access

Abstract

The FPIV-like late domains identified in the matrix (M) proteins of parainfluenza virus 5 and mumps virus have been demonstrated to be critical for virus budding. In this study, we found that the same FPIV sequence motif is present in the N-terminus of the Newcastle disease virus (NDV) M protein. Mutagenesis experiments demonstrated that mutation of either phenylalanine (F) or proline (P) to alanine led to a more obvious decrease in viral virulence and replication and resulted in poor budding of the mutant viruses. Additionally, evidence for the involvement of cellular multivesicular body (MVB) proteins was obtained, since NDV production was inhibited upon expression of dominant-negative versions of the VPS4A-E228Q protein. Together, these results demonstrate that the FPIV motif, especially the residues F and P, within the NDV M protein, plays a critical role in NDV replication and budding, and this budding process likely involves the cellular MVB pathway.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alexander DJ (1997) Newcastle disease and avian paramyxovirus infections. In: Calnek BW, Barnes HJ, Beard CW, McDougald LR (eds) Disease of poultry, 10th edn. Iowa State University Press, Ames, pp 541–569 Alexander DJ (1997) Newcastle disease and avian paramyxovirus infections. In: Calnek BW, Barnes HJ, Beard CW, McDougald LR (eds) Disease of poultry, 10th edn. Iowa State University Press, Ames, pp 541–569
2.
go back to reference Bieniasz PD (2006) Late budding domains and host proteins in enveloped virus release. Virology 344:55–63PubMedCrossRef Bieniasz PD (2006) Late budding domains and host proteins in enveloped virus release. Virology 344:55–63PubMedCrossRef
3.
go back to reference Ciancanelli MJ, Basler CF (2006) Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol 80:12070–12078PubMedCrossRefPubMedCentral Ciancanelli MJ, Basler CF (2006) Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol 80:12070–12078PubMedCrossRefPubMedCentral
4.
go back to reference Demirov DG, Orenstein JM, Freed EO (2002) The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J Virol 76:105–117PubMedCrossRefPubMedCentral Demirov DG, Orenstein JM, Freed EO (2002) The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J Virol 76:105–117PubMedCrossRefPubMedCentral
6.
go back to reference Duan Z, Li Q, He L, Zhao G, Chen J et al (2013) Application of green fluorescent protein-labeled assay for the study of subcellular localization of Newcastle disease virus matrix protein. J Virol Methods 194:118–122PubMedCrossRef Duan Z, Li Q, He L, Zhao G, Chen J et al (2013) Application of green fluorescent protein-labeled assay for the study of subcellular localization of Newcastle disease virus matrix protein. J Virol Methods 194:118–122PubMedCrossRef
8.
go back to reference Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH et al (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55–65PubMedCrossRef Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH et al (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55–65PubMedCrossRef
9.
go back to reference Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA (1991) Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 88:3195–3199PubMedCrossRefPubMedCentral Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA (1991) Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 88:3195–3199PubMedCrossRefPubMedCentral
10.
go back to reference Harrison MS, Sakaguchi T, Schmitt AP (2010) Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol 42:1416–1429PubMedCrossRefPubMedCentral Harrison MS, Sakaguchi T, Schmitt AP (2010) Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol 42:1416–1429PubMedCrossRefPubMedCentral
11.
go back to reference He L, Zhao G, Zhong L, Liu Q, Duan Z et al (2013) Isolation and characterization of two H5N1 influenza viruses from swine in Jiangsu Province of China. Arch Virol 158:2531–2541PubMedCrossRef He L, Zhao G, Zhong L, Liu Q, Duan Z et al (2013) Isolation and characterization of two H5N1 influenza viruses from swine in Jiangsu Province of China. Arch Virol 158:2531–2541PubMedCrossRef
12.
go back to reference Hu S, Ma H, Wu Y, Liu W, Wang X et al (2009) A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine 27:904–910PubMedCrossRef Hu S, Ma H, Wu Y, Liu W, Wang X et al (2009) A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine 27:904–910PubMedCrossRef
13.
go back to reference Hu S, Wang T, Liu Y, Meng C, Wang X et al (2010) Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein. Vet Microbiol 140:92–97PubMedCrossRef Hu S, Wang T, Liu Y, Meng C, Wang X et al (2010) Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein. Vet Microbiol 140:92–97PubMedCrossRef
14.
go back to reference Huang M, Orenstein JM, Martin MA, Freed EO (1995) p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol 69:6810–6818PubMedPubMedCentral Huang M, Orenstein JM, Martin MA, Freed EO (1995) p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol 69:6810–6818PubMedPubMedCentral
15.
go back to reference Irie T, Shimazu Y, Yoshida T, Sakaguchi T (2007) The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J Virol 81:2263–2273PubMedCrossRefPubMedCentral Irie T, Shimazu Y, Yoshida T, Sakaguchi T (2007) The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J Virol 81:2263–2273PubMedCrossRefPubMedCentral
16.
go back to reference Jayakar HR, Murti KG, Whitt MA (2000) Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol 74:9818–9827PubMedCrossRefPubMedCentral Jayakar HR, Murti KG, Whitt MA (2000) Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol 74:9818–9827PubMedCrossRefPubMedCentral
17.
go back to reference Li M, Schmitt PT, Li Z, McCrory TS, He B et al (2009) Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol 83:7261–7272PubMedCrossRefPubMedCentral Li M, Schmitt PT, Li Z, McCrory TS, He B et al (2009) Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol 83:7261–7272PubMedCrossRefPubMedCentral
18.
go back to reference Liu YL, Hu SL, Zhang YM, Sun SJ, Romer-Oberdorfer A et al (2007) Generation of a velogenic Newcastle disease virus from cDNA and expression of the green fluorescent protein. Arch Virol 152:1241–1249PubMedCrossRef Liu YL, Hu SL, Zhang YM, Sun SJ, Romer-Oberdorfer A et al (2007) Generation of a velogenic Newcastle disease virus from cDNA and expression of the green fluorescent protein. Arch Virol 152:1241–1249PubMedCrossRef
19.
go back to reference Martin-Serrano J, Yarovoy A, Perez-Caballero D, Bieniasz PD (2003) Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci USA 100:12414–12419PubMedCrossRefPubMedCentral Martin-Serrano J, Yarovoy A, Perez-Caballero D, Bieniasz PD (2003) Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci USA 100:12414–12419PubMedCrossRefPubMedCentral
20.
21.
go back to reference Pantua HD, McGinnes LW, Peeples ME, Morrison TG (2006) Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol 80:11062–11073PubMedCrossRefPubMedCentral Pantua HD, McGinnes LW, Peeples ME, Morrison TG (2006) Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol 80:11062–11073PubMedCrossRefPubMedCentral
22.
23.
go back to reference Perez M, Craven RC, de la Torre JC (2003) The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci USA 100:12978–12983PubMedCrossRefPubMedCentral Perez M, Craven RC, de la Torre JC (2003) The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci USA 100:12978–12983PubMedCrossRefPubMedCentral
24.
go back to reference Pornillos O, Garrus JE, Sundquist WI (2002) Mechanisms of enveloped RNA virus budding. Trends Cell Biol 12:569–579PubMedCrossRef Pornillos O, Garrus JE, Sundquist WI (2002) Mechanisms of enveloped RNA virus budding. Trends Cell Biol 12:569–579PubMedCrossRef
25.
go back to reference Puffer BA, Parent LJ, Wills JW, Montelaro RC (1997) Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol 71:6541–6546PubMedPubMedCentral Puffer BA, Parent LJ, Wills JW, Montelaro RC (1997) Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol 71:6541–6546PubMedPubMedCentral
26.
go back to reference Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Epidemiol 27:493–497 Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Epidemiol 27:493–497
27.
go back to reference Schmitt AP, Lamb RA (2004) Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr Top Microbiol Immunol 283:145–196PubMed Schmitt AP, Lamb RA (2004) Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr Top Microbiol Immunol 283:145–196PubMed
28.
go back to reference Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA (2005) Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol 79:2988–2997PubMedCrossRefPubMedCentral Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA (2005) Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol 79:2988–2997PubMedCrossRefPubMedCentral
29.
go back to reference Wills JW, Cameron CE, Wilson CB, Xiang Y, Bennett RP et al (1994) An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol 68:6605–6618PubMedPubMedCentral Wills JW, Cameron CE, Wilson CB, Xiang Y, Bennett RP et al (1994) An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol 68:6605–6618PubMedPubMedCentral
30.
go back to reference Wirblich C, Tan GS, Papaneri A, Godlewski PJ, Orenstein JM et al (2008) PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J Virol 82:9730–9738PubMedCrossRefPubMedCentral Wirblich C, Tan GS, Papaneri A, Godlewski PJ, Orenstein JM et al (2008) PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J Virol 82:9730–9738PubMedCrossRefPubMedCentral
Metadata
Title
Mutations in the FPIV motif of Newcastle disease virus matrix protein attenuate virus replication and reduce virus budding
Authors
Zhiqiang Duan
Zenglei Hu
Jie Zhu
Haixu Xu
Jian Chen
Huimou Liu
Shunlin Hu
Xiufan Liu
Publication date
01-07-2014
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2014
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-014-1998-2

Other articles of this Issue 7/2014

Archives of Virology 7/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine